SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 26.37-8.4%Jan 16 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cacaito who wrote (10502)6/18/1999 12:26:00 AM
From: aknahow  Read Replies (1) of 17367
 
Cacacito, thanks so much for the analysis.

I have thought of a motive for not telling us the trial has been concluded, if that is the case. The motive would be to make what someone considers a blockbuster announcement which combines the I-Prex deal with Trauma trial termination.

REMEMBER EVERYONE THIS IS SIMPLY A MENTAL EXERCISE. MAKE ALL YOUR BUY AND SELL DECISIONS BASED ON THE POST OF ROBERT K UNLESS HE TELLS YOU OTHERWISE.

I oppose waiting to combine the announcements. However there is another reason for the combination. As independent releases each is picked to pieces and made to seem less important. The result is less of a market impact than one would expect. But when two variables are combined in the same release the mind accepts the entire message as super positive.<g>

At any rate whenever XOMA stops providing accrual data on any future trial, I am going to posit that the trial has been halted. <g>
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext